Market Cap
Bristol-Myers Squibb Company
$119.95 Billion
USD as of Jan. 1, 2025
Company | Market Cap (USD) |
---|---|
![]() |
$689.42 B |
![]() |
$353.05 B |
![]() |
$301.60 B |
![]() |
$244.44 B |
![]() |
$219.35 B |
Company | Market Cap (USD) |
---|---|
![]() |
$689.42 B |
![]() |
$622.07 B |
![]() |
$487.54 B |
![]() |
$353.05 B |
![]() |
$301.60 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Bristol Myers Squibb Company, also known as BMS, is a multinational pharmaceutical company. Tracing its origins to1858, it develops and manufactures prescription pharmaceuticals and biologics for a diverse range of diseases including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.